{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:59:53Z","timestamp":1792807193251,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eplepsyres.2025.107553","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T21:31:41Z","timestamp":1743715901000},"page":"107553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The relationship between ghrelin, epilepsy-related inflammatory biomarkers (IL-1\u03b2, IL-1R1, HMGB1), and drug-resistant epilepsy in children"],"prefix":"10.1016","volume":"213","author":[{"given":"Bet\u00fcl","family":"Diler Durgut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beril","family":"Dilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fclay","family":"Kama\u015fak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer Faruk","family":"Saz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevriye Ceyda","family":"Kolayl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar \u00d6zkan","family":"Kart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Cansu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eplepsyres.2025.107553_bib1","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.3390\/ijms25126488","article-title":"A Systematic Review of the Predictive and Diagnostic Uses of Neuroinflammation Biomarkers for Epileptogenesis","volume":"25","author":"Aguilar-Castillo","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107553_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2011.03033.x","article-title":"Inflammation in epilepsy: clinical observations","volume":"52","author":"Aronica","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107553_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13311-013-0251-0","article-title":"Epilepsy related to developmental tumors and malformations of cortical development","volume":"11","author":"Aronica","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107553_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2011.04.019","article-title":"The effects of ghrelin on inflammation and the immune system","volume":"340","author":"Baatar","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107553_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.seizure.2005.11.008","article-title":"Serum ghrelin levels are enhanced in patients with epilepsy","volume":"15","author":"Berilgen","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2025.107553_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.eplepsyres.2025.107553_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-065X.2007.00574.x","article-title":"High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity","volume":"220","author":"Bianchi","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.eplepsyres.2025.107553_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fphys.2020.00601","article-title":"Interleukin 1 receptor 1 knockout and maternal high fat diet exposure induces sex-specific effects on adipose tissue adipogenic and inflammatory gene expression in adult mouse offspring","volume":"11","author":"Bridge-Comer","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107553_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/biomedicines10010053","article-title":"Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy","volume":"10","author":"Buckinx","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107553_bib10","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1111\/ene.14992","article-title":"Translational potential of the ghrelin receptor agonist macimorelin for seizure suppression in pharmacoresistant epilepsy","volume":"28","author":"Buckinx","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.eplepsyres.2025.107553_bib11","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3390\/ijms20102480","article-title":"Differential Effects of a Full and Biased Ghrelin Receptor Agonist in a Mouse Kindling Model","volume":"20","author":"Buckinx","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.eplepsyres.2025.107553_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.seizure.2018.03.013","article-title":"The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children","volume":"58","author":"\u00c7i\u00e7ek","year":"2018","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107553_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/jpm12040527","article-title":"Prospective Evaluation of Ghrelin and Des-Acyl Ghrelin Plasma Levels in Children with Newly Diagnosed Epilepsy: Evidence for Reduced Ghrelin-to-Des-Acyl Ghrelin Ratio in Generalized Epilepsies","volume":"12","author":"Costa","year":"2022","journal-title":"J. Pers. Med"},{"issue":"7","key":"10.1016\/j.eplepsyres.2025.107553_bib14","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1046\/j.1460-9568.2000.00140.x","article-title":"Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus","volume":"12","author":"De Simoni","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107553_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/1806-9282.67.02.20200521","article-title":"Evaluation of serum ghrelin, nesfatin-1, irisin, and vasoactive intestinal peptide levels in temporal lobe epilepsy patients with and without drug resistance: a cross-sectional study","volume":"67","author":"Erkec","year":"2021","journal-title":"Rev. Assoc. Med Bras. (1992)"},{"key":"10.1016\/j.eplepsyres.2025.107553_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109786","article-title":"Interictal interleukin-6 and tumor necrosis factor \u03b1 levels are associated with seizure recurrence in adults with epilepsy","volume":"155","author":"Fang","year":"2024","journal-title":"Epilepsy Behav."},{"issue":"11","key":"10.1016\/j.eplepsyres.2025.107553_bib17","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.3390\/ijms25115889","article-title":"Anti-HMGB1 mAb Therapy Reduces Epidural Hematoma Injury","volume":"25","author":"Gao","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107553_bib18","first-page":"3563","article-title":"Ghrelin improves pilocarpine-induced cerebral cortex inflammation in epileptic rats by inhibiting NF-\u03baB and TNF-\u03b1","volume":"18","author":"Han","year":"2018","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.eplepsyres.2025.107553_bib19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1212\/WNL.44.6.1030","article-title":"Medical treatment of Rasmussen\u2019s syndrome (chronic encephalitis and epilepsy): Effect of high-dose steroids or immunoglobulins in 19 patients","volume":"44","author":"Hart","year":"1994","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107553_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ghir.2008.12.001","article-title":"Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system","volume":"19","author":"Hattori","year":"2009","journal-title":"Growth Horm. IGF Res"},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107553_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1684\/epd.2020.1155","article-title":"HMGB-1, TLR4, IL-1R1, TNF-\u03b1, and IL-1\u03b2: novel epilepsy markers?","volume":"22","author":"Kama\u015fak","year":"2020","journal-title":"Epileptic Disord."},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107553_bib22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1590\/1806-9282.65.9.1188","article-title":"Modulatory effects of neuropeptides on pentylenetetrazol-induced epileptic seizures and neuroinflammation in rats","volume":"65","author":"Kilinc","year":"2019","journal-title":"Rev. Assoc. Med Bras. (1992)"},{"issue":"7413","key":"10.1016\/j.eplepsyres.2025.107553_bib23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nature11290","article-title":"Novel role of PKR in inflammasome activation and HMGB1 release","volume":"488","author":"Lu","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107553_bib24","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200634R","article-title":"Potential role of ghrelin in the regulation of inflammation","volume":"36","author":"Ma","year":"2022","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107553_bib25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.peptides.2010.11.023","article-title":"Relationship between total ghrelin and inflammation in hemodialysis patients","volume":"32","author":"Mafra","year":"2011","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107553_bib26","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1212\/WNL.0000000000005741","article-title":"High plasma levels of ghrelin and des-acyl ghrelin in responders to antiepileptic drugs","volume":"91","author":"Marchi\u00f2","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107553_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med"},{"key":"10.1016\/j.eplepsyres.2025.107553_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jphs.2019.04.006","article-title":"Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases","volume":"140","author":"Nishibori","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.eplepsyres.2025.107553_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.npep.2016.08.002","article-title":"The effect of leptin, ghrelin, and neuropeptide-Y on serum Tnf-\u0391, Il-1\u03b2, Il-6, Fgf-2, galanin levels and oxidative stress in an experimental generalized convulsive seizure model","volume":"61","author":"Oztas","year":"2017","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107553_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10571-022-01190-y","article-title":"Modulating Expression of Endogenous Interleukin 1 Beta in the Acute Phase of the Pilocarpine Model of Epilepsy May Change Animal Survival","volume":"43","author":"Pascoal","year":"2023","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2025.107553_bib31","article-title":"Anti-high mobility group box-1 monoclonal antibody attenuates seizure-induced cognitive decline by suppressing neuroinfammation in an adult zebrafsh model","volume":"11","author":"Paudel","year":"2020","journal-title":"Front Pharm."},{"issue":"7","key":"10.1016\/j.eplepsyres.2025.107553_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz130","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"142","author":"Pauletti","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2025.107553_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.04.004","article-title":"Des-acyl ghrelin attenuates pilocarpine-induced limbic seizures via the ghrelin receptor and not the orexin pathway","volume":"51","author":"Portelli","year":"2015","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107553_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1528-1167.2012.03423.x","article-title":"Ghrelin: an emerging new anticonvulsant neuropeptide","volume":"53","author":"Portelli","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107553_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2006.06.003","article-title":"The IL-1beta system in epilepsy-associated malformations of cortical development","volume":"24","author":"Ravizza","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.eplepsyres.2025.107553_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41583-024-00805-1","article-title":"mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment","volume":"25","author":"Ravizza","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107553_bib37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tem.2005.09.004","article-title":"Developments in ghrelin biology and potential clinical relevance","volume":"16","author":"Smith","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107553_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.pediatrneurol.2014.05.014","article-title":"Serum, urine, and saliva levels of ghrelin and obestatin pre- and post-treatment in pediatric epilepsy","volume":"51","author":"Taskin","year":"2014","journal-title":"Pedia Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107553_bib39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.coph.2010.04.015","article-title":"Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways","volume":"10","author":"Taub","year":"2010","journal-title":"Curr. Opin. Pharm."},{"issue":"Pt B","key":"10.1016\/j.eplepsyres.2025.107553_bib40","article-title":"Inflammation and reactive oxygen species in status epilepticus: Biomarkers and implications for therapy","volume":"101","author":"Terrone","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107553_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1535-7511.2007.00165.x","article-title":"New roles for interleukin-1 Beta in the mechanisms of epilepsy","volume":"7","author":"Vezzani","year":"2007","journal-title":"Epilepsy Curr."},{"issue":"12","key":"10.1016\/j.eplepsyres.2025.107553_bib42","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999","article-title":"Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures","volume":"19","author":"Vezzani","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107553_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Na Rev. Neurol."},{"issue":"7","key":"10.1016\/j.eplepsyres.2025.107553_bib44","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbi.2011.03.018","article-title":"IL-1 receptor\/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures","volume":"25","author":"Vezzani","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.eplepsyres.2025.107553_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2004.07.023","article-title":"Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy","volume":"17","author":"Voutsinos-Porche","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107553_bib46","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/epi.17116","article-title":"High-mobility group box 1 as a predictive biomarker for drug-resistant epilepsy: A proof-of-concept study","volume":"63","author":"Walker","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107553_bib47","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2017.02.002","article-title":"Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy","volume":"64","author":"Zhao","year":"2017","journal-title":"Brain Behav. Immun."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:35:21Z","timestamp":1746095721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":47,"alternative-id":["S0920121125000543"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107553","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between ghrelin, epilepsy-related inflammatory biomarkers (IL-1\u03b2, IL-1R1, HMGB1), and drug-resistant epilepsy in children","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107553"}}